Breaking News Instant updates and real-time market news.

CIEN

Ciena

$37.86 /

-0.25 (-0.66%)

07:55
12/02/19
12/02
07:55
12/02/19
07:55

Ciena Q4 results at risk due to transitory issues, says Cowen

Cowen analyst Paul Silverstein said his long-term thesis for Ciena remains unchanged but he believes there is near-term risk due to transitory issues. He said while trends remain favorable for long term revenues and margins, investor sentiment appears to be far more mixed. Silverstein reiterated his Outperform rating and $54 price target on Ciena shares.

  • 12

    Dec

CIEN Ciena
$37.86 /

-0.25 (-0.66%)

10/16/19 B. Riley FBR
B. Riley FBR remains cautious on Inphi and II-VI into Q3 results
10/02/19 Stifel
Ciena's recent weakness a buying opportunity, says Stifel
10/01/19 Goldman Sachs
Goldman adjusts Ciena Q1 estimates, says pullback overdone
10/01/19 Lynx
Ciena selloff on 'bogus' seasonality interpretation 'unwarranted,' says Lynx

TODAY'S FREE FLY STORIES

Downgrade
Choice Hotels downgraded to Neutral from Buy at Longbow » 05:24
09/28/20
09/28
05:24
09/28/20
05:24
CHH

Choice Hotels

$86.32 /

+1.56 (+1.84%)

Longbow analyst Alton…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHH Choice Hotels
$86.32 /

+1.56 (+1.84%)

CHH Choice Hotels
$86.32 /

+1.56 (+1.84%)

08/21/20 Wells Fargo
Choice Hotels price target raised to $104 from $95 at Wells Fargo
07/14/20 JPMorgan
Too early to turn bullish on Lodging stocks, says JPMorgan
06/25/20 Gordon Haskett
Choice Hotels initiated with a Hold at Gordon Haskett
06/22/20 Barclays
Choice Hotels price target raised to $82 from $73 at Barclays
CHH Choice Hotels
$86.32 /

+1.56 (+1.84%)

CHH Choice Hotels
$86.32 /

+1.56 (+1.84%)

CHH Choice Hotels
$86.32 /

+1.56 (+1.84%)

Upgrade
Naturgy Energy upgraded to Outperform from Underperform at RBC Capital » 05:23
09/28/20
09/28
05:23
09/28/20
05:23
GASNY

Naturgy Energy

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GASNY Naturgy Energy
$0.00 /

+ (+0.00%)

09/15/20 Morgan Stanley
Naturgy Energy upgraded to Equal Weight from Underweight at Morgan Stanley
09/09/20 HSBC
Naturgy Energy downgraded to Reduce from Hold at HSBC
09/09/20 HSBC
Naturgy Energy downgraded to Reduce from Hold at HSBC
08/19/20 Goldman Sachs
Naturgy Energy upgraded to Neutral from Sell at Goldman Sachs
Upgrade
Close Brothers upgraded to Hold from Sell at Investec » 05:22
09/28/20
09/28
05:22
09/28/20
05:22
CBGPY

Close Brothers

$0.00 /

+ (+0.00%)

Investec analyst Ian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBGPY Close Brothers
$0.00 /

+ (+0.00%)

07/24/20 Berenberg
Close Brothers price target lowered to 1,100 GBp from 1,170 GBp at Berenberg
07/06/20 Canaccord
Close Brothers upgraded to Hold from Sell at Canaccord
07/01/20 RBC Capital
Close Brothers upgraded to Outperform from Sector Perform at RBC Capital
05/27/20 Investec
Close Brothers downgraded to Sell from Hold at Investec
Initiation
Nifco initiated with an Outperform at SMBC Nikko » 05:21
09/28/20
09/28
05:21
09/28/20
05:21
NIFCY

Nifco

$0.00 /

+ (+0.00%)

SMBC Nikko initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NIFCY Nifco
$0.00 /

+ (+0.00%)

09/02/20 Mizuho
Nifco upgraded to Buy from Neutral at Mizuho
Hot Stocks
Genentech announces new two-year data from Part 1 of FIREFISH study » 05:21
09/28/20
09/28
05:21
09/28/20
05:21
RHHBY

Roche

$0.00 /

+ (+0.00%)

Genentech, a member of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/23/20 BMO Capital
Blueprint Medicines price target raised to $113 from $105 at BMO Capital
09/23/20 Oddo BHF
Roche downgraded to Reduce from Buy at Oddo BHF
09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Upgrade
Volvo upgraded to Buy from Hold at Nordea » 05:21
09/28/20
09/28
05:21
09/28/20
05:21
VOLVY

Volvo

$0.00 /

+ (+0.00%)

Nordea analyst Agnieszka…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VOLVY Volvo
$0.00 /

+ (+0.00%)

VOLVY Volvo
$0.00 /

+ (+0.00%)

09/24/20 Exane BNP Paribas
Volvo downgraded to Neutral from Outperform at Exane BNP Paribas
09/08/20 Bernstein
Volvo initiated with an Outperform at Bernstein
06/18/20 Jefferies
Volvo price target lowered to SEK 160 from SEK 190 at Jefferies
06/16/20 JPMorgan
Volvo upgraded to Overweight from Neutral at JPMorgan
Downgrade
Svenska Cellulosa AB downgraded to Hold from Buy at Nordea » 05:20
09/28/20
09/28
05:20
09/28/20
05:20
SVCBY

Svenska Cellulosa AB

$0.00 /

+ (+0.00%)

Nordea analyst Christian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SVCBY Svenska Cellulosa AB
$0.00 /

+ (+0.00%)

07/23/20 Jefferies
Svenska Cellulosa AB upgraded to Hold from Underperform at Jefferies
06/24/20 Danske Bank
Svenska Cellulosa AB downgraded to Hold from Buy at Danske Bank
06/17/20 UBS
Svenska Cellulosa AB price target raised to SEK 83 from SEK 81 at UBS
04/27/20 UBS
Svenska Cellulosa AB price target lowered to SEK 81 from SEK 82 at UBS
Upgrade
Plug Power upgraded to Overweight from Equal Weight at Morgan Stanley » 05:19
09/28/20
09/28
05:19
09/28/20
05:19
PLUG

Plug Power

$11.64 /

+0.39 (+3.47%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$11.64 /

+0.39 (+3.47%)

PLUG Plug Power
$11.64 /

+0.39 (+3.47%)

09/25/20 B. Riley FBR
Plug Power remains on track to 2024 targets, says B. Riley FBR
09/25/20 Barclays
Plug Power price target raised to $13 from $12 at Barclays
09/23/20 H.C. Wainwright
Plug Power expanding future opportunities with new deal, says H.C. Wainwright
08/03/20 H.C. Wainwright
Plug Power becoming 'go-to solution' for big box retailers, says H.C. Wainwright
PLUG Plug Power
$11.64 /

+0.39 (+3.47%)

  • 12
    Aug
  • 06
    Dec
PLUG Plug Power
$11.64 /

+0.39 (+3.47%)

PLUG Plug Power
$11.64 /

+0.39 (+3.47%)

PLUG Plug Power
$11.64 /

+0.39 (+3.47%)

Upgrade
Cleanaway upgraded to Outperform from Neutral at Credit Suisse » 05:18
09/28/20
09/28
05:18
09/28/20
05:18
TSPCF

Cleanaway Waste Management

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Qiagen upgraded to Buy from Hold at Kepler Cheuvreux » 05:16
09/28/20
09/28
05:16
09/28/20
05:16
QGEN

Qiagen

$51.97 /

+0.79 (+1.54%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QGEN Qiagen
$51.97 /

+0.79 (+1.54%)

QGEN Qiagen
$51.97 /

+0.79 (+1.54%)

08/26/20 Commerzbank
Qiagen upgraded to Buy from Hold at Commerzbank
08/24/20
Fly Intel: Top five analyst upgrades
08/24/20 Citi
Qiagen upgraded to Buy from Neutral at Citi
08/20/20 JPMorgan
Qiagen reinstated with an Overweight at JPMorgan
QGEN Qiagen
$51.97 /

+0.79 (+1.54%)

QGEN Qiagen
$51.97 /

+0.79 (+1.54%)

QGEN Qiagen
$51.97 /

+0.79 (+1.54%)

QGEN Qiagen
$51.97 /

+0.79 (+1.54%)

Hot Stocks
Xpeng subsidiary enters cooperation agreement for RMB4B in financing » 05:15
09/28/20
09/28
05:15
09/28/20
05:15
XPEV

Xpeng

$17.91 /

+0.45 (+2.58%)

XPeng announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPEV Xpeng
$17.91 /

+0.45 (+2.58%)

XPEV Xpeng
$17.91 /

+0.45 (+2.58%)

09/25/20 UBS
Xpeng initiated with a Buy at UBS
09/25/20 UBS
Xpeng initiated with a Buy at UBS
09/22/20 JPMorgan
Xpeng initiated with an Overweight at JPMorgan
09/21/20 BofA
Xpeng initiated with a Buy at BofA
  • 27
    Aug
XPEV Xpeng
$17.91 /

+0.45 (+2.58%)

XPEV Xpeng
$17.91 /

+0.45 (+2.58%)

Recommendations
Caesars bid 'significantly undervalues' William Hill, says Jefferies » 05:14
09/28/20
09/28
05:14
09/28/20
05:14
WIMHY

William Hill

$0.00 /

+ (+0.00%)

, CZR

Caesars

$57.19 /

+4.4 (+8.33%)

Jefferies analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WIMHY William Hill
$0.00 /

+ (+0.00%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

09/27/20 Jefferies
William Hill deal with Caesars makes strategic sense, says Jefferies
09/14/20 Jefferies
William Hill shares haven't priced in building U.S. momentum, says Jefferies
09/10/20 Berenberg
William Hill price target raised to 200 GBp from 150 GBp at Berenberg
09/09/20 Morgan Stanley
William Hill price target raised to 230 GBp from 200 GBp at Morgan Stanley
CZR Caesars
$57.19 /

+4.4 (+8.33%)

09/27/20 Jefferies
William Hill deal with Caesars makes strategic sense, says Jefferies
09/25/20 JPMorgan
Caesars price target raised to $63 from $55 at JPMorgan
09/24/20 Truist
Truist raises price targets on select Gaming names
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
CZR Caesars
$57.19 /

+4.4 (+8.33%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

Hot Stocks
Amazon announces Prime Day event on October 13, 14 » 05:12
09/28/20
09/28
05:12
09/28/20
05:12
AMZN

Amazon.com

$3,095.00 /

+76.79 (+2.54%)

Amazon's annual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

05:11 Today Baird
Amazon shares remain at 'attractive buying levels,' says Baird
09/24/20 Piper Sandler
Amazon.com assumed with an Overweight at Piper Sandler
09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/23/20 Piper Sandler
Amazon Care program expansion not a threat to Teladoc, says Piper Sandler
AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

Recommendations
Amazon shares remain at 'attractive buying levels,' says Baird » 05:11
09/28/20
09/28
05:11
09/28/20
05:11
AMZN

Amazon.com

$3,095.00 /

+76.79 (+2.54%)

Baird analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

09/24/20 Piper Sandler
Amazon.com assumed with an Overweight at Piper Sandler
09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/23/20 Piper Sandler
Amazon Care program expansion not a threat to Teladoc, says Piper Sandler
09/23/20 Benchmark
Benchmark says Microsoft partnership can be 'big driver' for Kratos
AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

AMZN Amazon.com
$3,095.00 /

+76.79 (+2.54%)

Recommendations
Mirum opportunity in Alagille syndrome higher than expected, says Piper Sandler » 05:08
09/28/20
09/28
05:08
09/28/20
05:08
MIRM

Mirum Pharmaceuticals

$18.78 /

-0.1 (-0.53%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MIRM Mirum Pharmaceuticals
$18.78 /

-0.1 (-0.53%)

MIRM Mirum Pharmaceuticals
$18.78 /

-0.1 (-0.53%)

09/09/20 Guggenheim
Mirum Pharmaceuticals price target raised to $38 from $27 at Guggenheim
09/01/20 Citi
Mirum Pharmaceuticals price target raised to $31 from $28 at Citi
08/07/20 Raymond James
Mirum Pharmaceuticals upgraded to Strong Buy from Outperform at Raymond James
08/07/20 Raymond James
Mirum Pharmaceuticals upgraded to Strong Buy from Outperform at Raymond James
MIRM Mirum Pharmaceuticals
$18.78 /

-0.1 (-0.53%)

  • 09
    Jan
Hot Stocks
Caesars says joint venture with William Hill 'needs to be broadened' » 05:03
09/28/20
09/28
05:03
09/28/20
05:03
CZR

Caesars

$57.19 /

+4.4 (+8.33%)

, WIMHY

William Hill

$0.00 /

+ (+0.00%)

Caesars (CZR) said it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CZR Caesars
$57.19 /

+4.4 (+8.33%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

09/27/20 Jefferies
William Hill deal with Caesars makes strategic sense, says Jefferies
09/25/20 JPMorgan
Caesars price target raised to $63 from $55 at JPMorgan
09/24/20 Truist
Truist raises price targets on select Gaming names
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
WIMHY William Hill
$0.00 /

+ (+0.00%)

09/27/20 Jefferies
William Hill deal with Caesars makes strategic sense, says Jefferies
09/14/20 Jefferies
William Hill shares haven't priced in building U.S. momentum, says Jefferies
09/10/20 Berenberg
William Hill price target raised to 200 GBp from 150 GBp at Berenberg
09/09/20 Morgan Stanley
William Hill price target raised to 230 GBp from 200 GBp at Morgan Stanley
CZR Caesars
$57.19 /

+4.4 (+8.33%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

Hot Stocks
Caesars says U.S. joint venture with William Hill would end in Apollo buyout » 05:01
09/28/20
09/28
05:01
09/28/20
05:01
CZR

Caesars

$57.19 /

+4.4 (+8.33%)

, WIMHY

William Hill

$0.00 /

+ (+0.00%)

, APO

Apollo Global

$44.72 /

+1.865 (+4.35%)

Caesars Entertainment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CZR Caesars
$57.19 /

+4.4 (+8.33%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

APO Apollo Global
$44.72 /

+1.865 (+4.35%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

09/27/20 Jefferies
William Hill deal with Caesars makes strategic sense, says Jefferies
09/25/20 JPMorgan
Caesars price target raised to $63 from $55 at JPMorgan
09/24/20 Truist
Truist raises price targets on select Gaming names
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
WIMHY William Hill
$0.00 /

+ (+0.00%)

09/27/20 Jefferies
William Hill deal with Caesars makes strategic sense, says Jefferies
09/14/20 Jefferies
William Hill shares haven't priced in building U.S. momentum, says Jefferies
09/10/20 Berenberg
William Hill price target raised to 200 GBp from 150 GBp at Berenberg
09/09/20 Morgan Stanley
William Hill price target raised to 230 GBp from 200 GBp at Morgan Stanley
APO Apollo Global
$44.72 /

+1.865 (+4.35%)

07/01/20 Barclays
Apollo Global price target raised to $51 from $44 at Barclays
06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Goldman Sachs
Apollo Global downgraded to Buy from Conviction Buy at Goldman Sachs
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
CZR Caesars
$57.19 /

+4.4 (+8.33%)

APO Apollo Global
$44.72 /

+1.865 (+4.35%)

  • 26
    Nov
CZR Caesars
$57.19 /

+4.4 (+8.33%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

APO Apollo Global
$44.72 /

+1.865 (+4.35%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

APO Apollo Global
$44.72 /

+1.865 (+4.35%)

CZR Caesars
$57.19 /

+4.4 (+8.33%)

APO Apollo Global
$44.72 /

+1.865 (+4.35%)

Downgrade
Copa Holdings downgraded to Underweight from Overweight at Barclays » 04:58
09/28/20
09/28
04:58
09/28/20
04:58
CPA

Copa Holdings

$55.95 /

+1.44 (+2.64%)

Barclays analyst Pablo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPA Copa Holdings
$55.95 /

+1.44 (+2.64%)

CPA Copa Holdings
$55.95 /

+1.44 (+2.64%)

09/15/20 Seaport Global
Copa Holdings initiated with a Neutral at Seaport Global
08/17/20 Citi
Copa Holdings price target raised to $59 from $51 at Citi
06/22/20 Raymond James
Copa Holdings downgraded to Outperform from Strong Buy at Raymond James
06/22/20 Raymond James
Copa Holdings downgraded to Outperform from Strong Buy at Raymond James
CPA Copa Holdings
$55.95 /

+1.44 (+2.64%)

Upgrade
Huntsman upgraded to Equal Weight from Underweight at Barclays » 04:57
09/28/20
09/28
04:57
09/28/20
04:57
HUN

Huntsman

$21.36 /

+0.095 (+0.45%)

Barclays analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUN Huntsman
$21.36 /

+0.095 (+0.45%)

HUN Huntsman
$21.36 /

+0.095 (+0.45%)

09/16/20 Stifel
Huntsman initiated with a Buy at Stifel
09/09/20 Truist
Huntsman price target raised to $26 from $25 at Truist
09/09/20 KeyBanc
Huntsman price target raised to $29 from $23 at KeyBanc
08/31/20 Goldman Sachs
Huntsman price target raised to $25 from $21 at Goldman Sachs
HUN Huntsman
$21.36 /

+0.095 (+0.45%)

HUN Huntsman
$21.36 /

+0.095 (+0.45%)

HUN Huntsman
$21.36 /

+0.095 (+0.45%)

HUN Huntsman
$21.36 /

+0.095 (+0.45%)

Upgrade
Merit Medical upgraded to Equal Weight from Underweight at Wells Fargo » 04:57
09/28/20
09/28
04:57
09/28/20
04:57
MMSI

Merit Medical

$41.37 /

+0.57 (+1.40%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

07/30/20 Barrington
Merit Medical price target raised to $54 from $49 at Barrington
07/30/20 Piper Sandler
Merit Medical price target raised to $55 from $50 at Piper Sandler
05/27/20 Barrington
Merit Medical price target raised to $49 from $42 at Barrington
05/26/20 Piper Sandler
Piper Sandler positive on Merit Medical's Starboard agreement on board members
MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

Upgrade
Itron upgraded to Strong Buy from Outperform at Raymond James » 04:56
09/28/20
09/28
04:56
09/28/20
04:56
ITRI

Itron

$56.24 /

+0.79 (+1.42%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITRI Itron
$56.24 /

+0.79 (+1.42%)

ITRI Itron
$56.24 /

+0.79 (+1.42%)

08/25/20 Wolfe Research
Itron initiated with an Underperform at Wolfe Research
08/04/20 Oppenheimer
Itron price target lowered to $75 from $82 at Oppenheimer
06/26/20 Oppenheimer
Itron price target lowered to $82 from $90 at Oppenheimer
05/26/20 Johnson Rice
Itron initiated with a Buy at Johnson Rice
ITRI Itron
$56.24 /

+0.79 (+1.42%)

ITRI Itron
$56.24 /

+0.79 (+1.42%)

Conference/Events
Sarepta to hold a conference call » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
SRPT

Sarepta

$143.72 /

+5.96 (+4.33%)

Management discuss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRPT Sarepta
$143.72 /

+5.96 (+4.33%)

SRPT Sarepta
$143.72 /

+5.96 (+4.33%)

09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/10/20 Piper Sandler
Sarepta filing for SRP-9001 could still meet expectations, says Piper Sandler
09/10/20 Mizuho
Sarepta potential study delay 'largely immaterial,' says Mizuho
09/10/20 Goldman Sachs
Sarepta Phase 3 timelines 'could remain intact,' says Goldman Sachs
SRPT Sarepta
$143.72 /

+5.96 (+4.33%)

SRPT Sarepta
$143.72 /

+5.96 (+4.33%)

Conference/Events
L.B. Foster to host conference call » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
FSTR

L.B. Foster

$12.16 /

-0.11 (-0.90%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSTR L.B. Foster
$12.16 /

-0.11 (-0.90%)

FSTR L.B. Foster
$12.16 /

-0.11 (-0.90%)

06/09/20 B. Riley FBR
L.B. Foster transferred with Buy, $18 target at B. Riley FBR
05/06/20 B. Riley FBR
L.B. Foster price target lowered to $20 from $30 at B. Riley FBR
Conference/Events
Essent Group management to meet virtually with BTIG » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
ESNT

Essent Group

$35.71 /

+0.595 (+1.69%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESNT Essent Group
$35.71 /

+0.595 (+1.69%)

ESNT Essent Group
$35.71 /

+0.595 (+1.69%)

09/21/20
Fly Intel: Top five analyst initiations
09/21/20 Goldman Sachs
Essent Group initiated with a Buy at Goldman Sachs
06/09/20 Keefe Bruyette
Essent Group downgraded to Market Perform from Outperform at Keefe Bruyette
06/03/20 Credit Suisse
Essent Group price target raised to $38 from $32 at Credit Suisse
ESNT Essent Group
$35.71 /

+0.595 (+1.69%)

  • 29
    May
ESNT Essent Group
$35.71 /

+0.595 (+1.69%)

General news
Dallas Fed Manufacturing Survey General Activity Index to be reported at 10:30 » 04:55
09/28/20
09/28
04:55
09/28/20
04:55

September Dallas Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.